readthroughSign in
CompanySLXNSLXNWNasdaqRamat Gan, L3

Silexion Therapeutics Corp

Silexion Therapeutics develops siRNA therapeutics targeting KRAS-mutant solid tumors.

8-KNov 16Latest SEC filing
Nov 16Latest story